M2613

M2613 is a nonsteroidal estrogen derived from triphenylbromoethylene which was studied in the treatment of breast cancer in females in the 1940s but was never marketed.

M2613
Clinical data
Other namesM-2613; Methoxyethoxy-triphenylbromoethylene
Drug classNonsteroidal estrogen
Identifiers
  • 1-Bromo-2-(p-ethoxyphenyl)-2-(p-methoxyphenyl)-1-phenylethylene
CAS Number
Chemical and physical data
FormulaC23H21BrO2
Molar mass409.323 g·mol−1
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.